Cytori Therapeutics Inc Series S Warrant
CYTXZ
CYTXZ was delisted on the 23rd of July, 2019.
0 hedge funds and large institutions have $0 invested in Cytori Therapeutics Inc Series S Warrant in 2019 Q3 according to their latest regulatory filings, with funds opening new positions, increasing their positions, 0 reducing their positions, and 5 closing their positions.
100% less funds holding
Funds holding: 5 → 0 (-5)
100% less capital invested
Capital invested by funds: $1K → $0 (-$1K)
100% less first-time investments, than exits
New positions opened: 0 | Existing positions closed: 5
Top Buyers
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
CH
CVI Holdings
Wilmington,
Delaware
|
-$1K |
CYTXZ Hedge Fund Activity: Q3 2019 in Review
0 of the 4,574 institutional investors tracked by Wall St. Rank reported a position in Cytori Therapeutics Inc Series S Warrant (CYTXZ) for Q3 2019, worth a combined $0 — down 100% from $1K a quarter earlier.
Sellers outnumbered buyers: 5 funds closed out of CYTXZ and 0 opened new positions — a net loss of 5 holders — while 0 trimmed existing stakes and 0 added.
The largest seller was CVI Holdings, exiting entirely with an estimated $1K sold.
- 0 institutional investors held Cytori Therapeutics Inc Series S Warrant (CYTXZ) as of Q3 2019, down from 5 in Q2 2019.
- Funds reported $0 of Cytori Therapeutics Inc Series S Warrant stock for Q3 2019, down 100% quarter-over-quarter.
- 0 funds opened new Cytori Therapeutics Inc Series S Warrant positions in Q3 2019 and 5 closed out, a net change of -5 holders.
- The largest Cytori Therapeutics Inc Series S Warrant seller in Q3 2019 was CVI Holdings, an estimated $1K sold.
Based on aggregated 13F filings for Q3 2019.